Generic name:pegfilgrastim-apgf (subcutaneous route) [ peg-fil-GRA-stim-- apgf ]
Drug class:Colony stimulating factors
Medically reviewed by Drugs.com. Last updated on Feb 19, 2022.
Commonly used brand name(s)
In the U.S.
- Nyvepria
Available Dosage Forms:
- Solution
Therapeutic Class: Hematopoietic
Pharmacologic Class: Pegfilgrastim
Uses for Nyvepria
Pegfilgrastim-apgf injection is used to treat neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic (man-made) form of a substance that is naturally produced in your body called a colony stimulating factor. Pegfilgrastim-apgf helps the bone marrow to make new white blood cells.
When certain cancer medicines are used to fight cancer cells, they also affect the white blood cells that fight infections. Pegfilgrastim-apgf is used to reduce the risk of infection while you are being treated with cancer medicines.
This medicine is available only with your doctor's prescription.
Before using Nyvepria
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of pegfilgrastim-apgf injection in the pediatric population.
Geriatric
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of pegfilgrastim-apgf in the elderly.
Breastfeeding
There are no adequ...
